Novel low-frequency maternal mosaicism mutation of CHRDL1 gene resulted in the X-linked megalocornea in the offspring
Author affiliations
DOI:
https://doi.org/10.15625/vjbt-21531Keywords:
megalocornea, anterior segment dysgenesis, CHRDL1 gene, whole exome sequencing, hemizygous variantAbstract
X-linked megalocornea (MGC1) is an inherited disorder resulting from mutations of the CHRDL1 gene. Common symptoms of megalocornea include oversized cornea, deeper fluid-filled space between the cornea and iris, blurred or distorted vision at every distance, leading to mild vision issues. In this report, we present the first cases of megalocornea caused by the maternal low-frequency somatic mosaicism of the novel CHRDL1 mutation. Two Vietnamese siblings, 5 years old (MG001) and 13 years old (MG002) visited the hospital for regular check-ups with manifestations such as myopic, exophthalmia, and enlarged cornea. They were suspected of having inherited megalocornea disorder without glaucoma symptoms. The DNA genome of the proband (MG001) was applied for whole exome sequencing (WES) analysis, and the result revealed a hemizygous pathogenic variant c.943dupA in the CHRDL1 gene, which results in a frameshift mutation (p.Ile315fs) in protein. This mutation was also identified in the proband (MG002) by Sanger sequencing. Notably, the CHRDL1 c.943dupA mutation was recognized at a very low fraction in the maternal DNA after triplicate Sanger sequencing, indicating that the mother has a mosaicism mutation of CHRDL1 c.943dupA. This study reported a rare case of X-linked megalocornea in a family and provides a novel genetic factor relating to an eye disorder in Vietnam.
Downloads
References
Yu M, Bouhenni R, Kurup SK, He W. Editorial: Genetic Mutations Associated with Ocular Diseases. Front Cell Dev Biol. 2021 Dec 24;9:815522. https://doi.org/10.3389/FCELL.2021.815522/BIBTEX
Mao M, Kiss MM, Ou Y, Gould DB. Genetic dissection of anterior segment dysgenesis caused by a Col4a1 mutation in mouse. Dis Model Mech. 2017;10 (4):475–85; https://doi.org/10.1242/dmm.027888
Davidson AE, Cheong SS, Hysi PG, Venturini C, Plagnol V. Association of CHRDL1 Mutations and Variants with X-linked Megalocornea, Neuhäuser Syndrome and Central Corneal Thickness. PLoS One [Internet]. 2014 [cited 2023 Dec 14];9(8):2012–6. https://doi.org/10.1371/journal.pone.0104163
Tuft SJ. Corneal abnormalities in childhood. Taylor and Hoyt’s Pediatric Ophthalmology and Strabismus, Fifth Edition. 2016 Jan 1;314–29. https://doi.org/10.1016/B978-0-7020-6616-0.00034-7
Sakuta H, Suzuki R, Takahashi H, Kato A, Shintani T, Iemura SI, et al. Ventroptin: a BMP-4 antagonist expressed in a double-gradient pattern in the retina. Science [Internet]. 2001 Jul 6 [cited 2023 Dec 15];293(5527):111–5. https://doi.org/10.1126/SCIENCE.1058379
Webb TR, Matarin M, Gardner JC, Kelberman D, Hassan H, Ang W, et al. X-Linked Megalocornea Caused by Mutations in CHRDL1 Identifies an Essential Role for Ventroptin in Anterior Segment Development. Am J Hum Genet [Internet]. 2012 Feb 2 [cited 2023 Dec 15];90(2):247–59. https://doi.org/10.1016/J.AJHG.2011.12.019
Moshirfar M, Hastings J, Ronquillo Y. Megalocornea. StatPearls [Internet]. 2023 Jul 18 [cited 2023 Dec 14]; https://www.ncbi.nlm.nih.gov/books/NBK554374/
Ong APC, Zhang J, Vincent AL, McGhee CNJ. Megalocornea, anterior megalophthalmos, keratoglobus and associated anterior segment disorders: A review. Clin Exp Ophthalmol [Internet]. 2021 Jul 1 [cited 2024 May 9];49(5):477–97. https://doi.org/10.1111/CEO.13958
Pfirrmann T, Emmerich D, Ruokonen P, Quandt D, Buchen R, Fischer-Zirnsak B, et al. Molecular mechanism of CHRDL1-mediated X-linked megalocornea in humans and in Xenopus model monogenic cornea disorders like XMC-with presumably disturbed cornea growth and differentiation-contribute to the identification of potential limbal stem cell niche factors that are promising targets for regenerative therapies of corneal injuries. Hum Mol Genet [Internet]. 2015 [cited 2024 Jan 3];24(11):3119–32. https://doi.org/10.1093/hmg/ddv063
Walker H, Akula M, West-Mays JA. Corneal development: Role of the periocular mesenchyme and bi-directional signaling. Exp Eye Res. 2020 Dec 1;201:108231. https://doi.org/10.1016/J.EXER.2020.108231
Scuderi G, Contestabile MT, Scuderi L, Librando A, Fenicia V, Rahimi S. Pigment dispersion syndrome and pigmentary glaucoma: a review and update. Int Ophthalmol [Internet]. 2019 Jul 15 [cited 2024 Jan 3];39(7):1651–62. https://doi.org/10.1007/S10792-018-0938-7
Mohamed Q, Zamir E. Update on Fuchs’ uveitis syndrome. Curr Opin Ophthalmol [Internet]. 2005 Dec [cited 2024 Jan 3];16(6):356–63. https://doi.org/10.1097/01.ICU.0000187056.29563.8D
Downloads
Published
How to Cite
Issue
Section
License
Vietnam Journal of Biotechnology is a peer-reviewed, open access journal dedicated to the dissemination of scientific knowledge and research findings in the field of biotechnology. All published articles are freely accessible and downloadable by readers worldwide without any subscription or access fees.
All articles published in Vietnam Journal of Biotechnology are distributed under the terms of the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) License. This license allows users to share, copy, redistribute, adapt, and reproduce the material in any medium or format, provided that appropriate credit is given to the original author(s) and source, and that any derivative works are distributed under the same license terms.
The copyright of each published article remains with the respective author(s) without restriction. By submitting and granting permission for publication through the journal’s submission system or other communication channels, authors authorize Vietnam Journal of Biotechnology to publish and identify itself as the original publisher of the work. Authors also acknowledge and agree to comply with the terms and conditions of the CC BY-SA 4.0 License and the policies established by the journal.
